Skip to content

Change of lungfunction after inhaling rescue asthma medication in different amounts in straight up and forward leaning body posture in asthmatic children

Reversibility of pulmonary function after inhaling salbutamol in different doses in standard and forward leaning body posture in asthmatic children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22687
Enrollment
15
Registered
2013-09-29
Start date
2014-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma Dutch: astma

Interventions

four times spirometry, one time with the inhalation of 200ugr salbutamol in the standard body posture, one time 200ugr salbutamol in the forward leaning body posture with the head flexed backwards and

Sponsors

Medisch Spectrum Twente, Enschede
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Clinical history of asthma symptoms. - Age 6 till 16 years old. - Ability to perform reproducible pulmonary function tests, i.e. coefficient of the predicted value variation in 3 of 5 consecutive measurements < 5%.

Exclusion criteria

Exclusion criteria: - Exacerbation in the last 4 weeks prior to the study (hospital admission or use of systemic corticosteroids). - Use of long acting bronchodilators 24 hours before testing. - Use of short acting bronchodilators 8 hours before testing. - Use of leukotriene antagonists 24 hours before testing. - Other pulmonary or cardiac disorder.

Design outcomes

Primary

MeasureTime frame
FEV1, VC, PEF, MEF25 and MEF75 reversibility (%)

Secondary

MeasureTime frame
Possible discomfort body posture measured with VAS scores Possible side effects of the salbutamol inhalation: number of children complaining about palpitations, tremor, discomfort or rash.

Contacts

Public ContactR. Visser

Medisch Spectrum Twente Departement of pediatrics Haaksbergerstraat 55

R.Visser@mst.nl+31 (0)53 4872310

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)